Divi's Laboratories Limited's total liabilities is $-170B.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (June 2026), DIVISLAB.NS shows a total liabilities of $-170B. That compares with $-150B in the prior-year period — down 12.0% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, DIVISLAB.NS's total liabilities is now $-170B (was $-150B) — a 12.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Divi's Laboratories Limited is outperforming or lagging.
Tracking DIVISLAB.NS's total liabilities over time shows whether Divi's Laboratories Limited is scaling, shrinking, or reshaping that part of the business. The current reading is $-170B That compares with $-150B in the prior-year period — down 12.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this total liabilities page, Stockcircle has Divi's Laboratories Limited's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $-170B) with ownership activity and broader fundamentals.